Company Filing History:
1 out of 775 
1 out of 3 Years Active: 2012
Title: The Innovative Contributions of Shuhei Kato
Introduction
Shuhei Kato is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of diabetes management through his innovative patent. His work focuses on improving the estimation of blood glucose excursions in diabetic patients, which is crucial for effective treatment and management of the condition.
Latest Patents
Shuhei Kato holds a patent for a method of estimation of blood glucose excursions in diabetic patients using the 1,5-anhydroglucitol (1,5-AG) assay. This invention provides a method for measuring blood glucose excursions in general, and postprandial hyperglycemia in diabetic patients in particular. The 1,5-AG assay is particularly useful for identifying diabetic patients who may be at risk for cardiovascular complications that would not be identifiable by A1C levels alone. The ratios of A1C divided by 1,5-AG in each patient serve as superior indicators compared to 1,5-AG levels alone.
Career Highlights
Throughout his career, Shuhei Kato has worked with prominent companies such as Nippon Kayaku and Toyota Tsusho America, Inc. His experience in these organizations has contributed to his expertise in the field of diabetes research and innovation.
Collaborations
Shuhei Kato has collaborated with esteemed professionals in the field, including John Bernard Buse and Kathleen Dungan. These collaborations have further enhanced the impact of his work on diabetes management.
Conclusion
Shuhei Kato's innovative contributions to diabetes management through his patent demonstrate his commitment to improving patient care. His work continues to influence the field and offers valuable insights for future research and development.